Jonathan Iwry

Associate

  • JD, Harvard Law School, 2020; Executive Editor, Harvard Negotiation Law Review; Senior Submissions Editor, Harvard Business Law Review
  • BA, summa cum laude, University of Pennsylvania, 2014

Qualifications

  • Massachusetts, 2021
  • Hebrew

Jonathan Iwry

Associate

Jonathan Iwry joined Ropes & Gray’s corporate department in October 2021 and practices in the strategic transactions group. While at Harvard Law School, Jonathan served as a senior submissions editor of the Harvard Business Law Review and as the president of the Recording Artists Project, Harvard’s student practice organization for music law. He also participated in the Cyberlaw Clinic, where he worked on policy proposals and legal issues involving artificial intelligence and IP on behalf of Harvard’s Berkman Klein Center. In addition, Jonathan served as a teaching fellow for courses in Harvard College, including Professor Michael Sandel’s course on justice and moral-political philosophy (known as “the Justice course”).

Jonathan graduated from the University of Pennsylvania summa cum laude with a B.A. in Philosophy and History. During college, he spent a summer at the House Judiciary Committee and a summer in the law offices of a Maryland criminal defense attorney. He has co-authored a number of academic articles and book chapters on topics involving negotiation, psychology and machine learning, neurotechnology, and FDA emergency use authorization. Before attending law school, he also worked as a research assistant with the late Professor Mark Kleiman of NYU on policy initiatives applying behavioral economics to drug policy reform.

Publications

  • Author, “FDA Emergency Use Authorization From 9/11 to COVID-19: Historical Lessons and Ethical Challenges,” Food and Drug Law Institute’s Food and Drug Law Journal (October 2021) Published with permission of FDLI and the Food and Drug Law Journal
  • Jonathan Iwry, “FDA Emergency Use Authorization: A Brief History From 9/11 to COVID-19,” Update Magazine (October 2021)
  • Jonathan Iwry, “Open to Debate: Reducing Polarization by Approaching Political Argument as Negotiation,” Negotiation Journal (2021)
  • Jonathan Iwry, “’Stick to the Science’? FDA, Ethics, and Pandemics,” Bill of Health (June 17, 2021)
  • Jonathan Iwry, “From 9/11 to COVID-19: A Brief History of FDA Emergency Use Authorization,” COVID-19 and the Law (January 14, 2021)
  • Co-author, “Closed- and Open-Vocabulary Approaches to Text Analysis: A Review, Quantitative Comparison, and Recommendations,” Psychological Methods (2020)
  • Co-author, “Noninvasive Brain Stimulation and Personal Identity: Ethical Considerations,” Frontiers in Human Neuroscience (2017)
  • Co-author, “Secularism and the Science of Well-Being,” Oxford Handbook of Secularism (2017)
  • Co-author, “Neuroscience and Religion: Surveying the Field,” Macmillan Interdisciplinary Handbooks: Religion (2016)
  • Jonathan Iwry, “Groupthink and Polarization: A Tale of Redistricting,” Penn Political Review (May 2014)

Presentations

  • Speaker, “How We Got Here: FDA Emergency Use Authorization from 9/11 to COVID-19,” Food and Drug Law Journal 2020 Symposium, Washington, D.C. (November 13, 2020)
  • JD, Harvard Law School, 2020; Executive Editor, Harvard Negotiation Law Review; Senior Submissions Editor, Harvard Business Law Review
  • BA, summa cum laude, University of Pennsylvania, 2014

Qualifications

  • Massachusetts, 2021
Cookie Settings